Irkutsk, Irkutsk region, Russian Federation
We studied the effect of furosemide application at the pre-hospital stage on survival rate and mortality risk in patients with acute respiratory distress syndrome. It was found that out of 665 patients admitted to intensive care units, 90 have been diagnosed with acute respiratory distress syndrome, of which 75 have noted decreased preload. Those patients were divided into two groups: group 1 (n = 28) received furosemide on the first day, group 2 (n = 47) did not receive furosemide. The patients of both groups matched by age, the severity of the condition and the severity of organ dysfunction. The 10-day survival rate in the patients with acute respiratory distress syndrome and reduced preload received furosemide at the pre-hospital stage made 11 % and was significantly lower than in the patients without furosemide– 43 % (p = 0.031). The frequency of multiple organ dysfunction syndrome in group 1 the was statistically higher than in patients without furosemide (93 % and 75 % respectively; p = 0.048). Furosemide admin-istration in patients with acute respiratory distress syndrome and reduced preload 1.8 times increases the relative mortality risk (p = 0.032).
acute respiratory distress syndrome, survival, risk factors for mortality, preload
1. VertkinAL, GorodetskiyVV, TalibovOB (2002). Acute heart failure: diagnostics and treatment at the pre-hospital stage [Ostraya serdechnaya nedostatochnost’: diagnostika i lechenie na dogospital’nom etape]. Lechashchiy vrach, (9), 16-19.
2. DatsAV, GorbachyovaSM, DatsLS (2009). Influence of hypovolemia on mortality and multiorgan failure syn-drome [Vliyanie gipovolemii na letal’nost’ i formirovanie sindroma poliorgannoy nedostatochnosti]. Sibirskiy med-itsinskiy zhurnal (Irkutsk), 7(1), 57-59.
3. Diagnostics and treatment of acute heart failure: Recommendations of All-Russian Scientific Society of Cardiologists [Diagnostika i lechenie ostroy serdechnoy nedostatochnosti: rekomendatsii Vserossiyskogo nauch-nogo obshchestva kardiologov] (2006). Kardiovaskulyar-naya terapiya i profilaktika, 5(6).
4. GelfandBR (ed.) (2009). Infusion and transfusion therapy in clinical medicine: manual for physicians [Infuz-ionno-transfuzionnaya terapiya v klinicheskoy meditsine: rukovodstvo dlya vrachey], 256.
5. CooperN, ForrestK, CrampP (2008). Essential guide to acute care [Neotlozhnye sostoyaniya: printsipy korrektsii], 216.
6. AllmanK, WilsonI (2009). Oxford handbook of anes-thesia [Oksfordskiy spravochnik po anestezii], 367.
7. SueDY, VintchJ (2008). Current essentials of critical care [Intensivnaya terapiya: sovremennye aspekty], 335.
8. ARDS Clinical Trial Network: comparison of two fluid-management strategies in acute lung injury (2006). N. Engl. J. Med., 15(354), 2564-2575.
9. BernardGR, ArtigasA, BrighamKL (1994). The American-European Consensus Conference on ARDS. Am. J. Resp. Crit. Care Med., (149), 818-824.
